Target intelligence / Profile preview

Cell-to-cell contact

Molecular classification
Cell adhesion molecule, Connexin, Immune checkpoint, Notch signaling component
01

Overview

Cell-to-cell contact, also known as juxtacrine or contact-dependent signaling, is a fundamental biological process where physical interaction between adjacent cells mediates signal transmission [2, 6]. This communication is facilitated by diverse molecular structures, including cell adhesion molecules like cadherins and integrins, gap junctions composed of connexins, and membrane-bound ligand-receptor pairs such as Notch-Delta and PD-1/PD-L1 [1, 3, 6]. These interactions are essential for coordinating physiological functions including embryonic development, immune system activation, and the maintenance of tissue architecture [4, 7]. In pathological states, dysregulated cell-to-cell contact plays a pivotal role in cancer metastasis through the epithelial-mesenchymal transition and immune evasion via checkpoint signaling [1, 2, 8]. Furthermore, certain pathogens, such as HIV and HTLV-1, exploit direct cell-to-cell contact via virological synapses to spread efficiently while avoiding neutralizing antibodies [9, 13]. Therapeutic strategies targeting these pathways include monoclonal antibodies that block adhesion or immune checkpoints, as well as small molecules intended to modulate gap junction permeability or disrupt cell-mediated viral dissemination [1, 2, 8, 13].

Other names
Juxtacrine signalingContact-dependent signalingDirect intercellular communicationCell-cell interaction
02

Mechanism of action

Inhibition of cell adhesion via integrin blockade, disruption of immune checkpoint interactions, modulation of gap junction permeability, and inhibition of contact-dependent viral transmission [1, 2, 8, 13].

03

Biological functions

Signal transductionCell adhesionImmune responseEmbryonic developmentTissue homeostasisCollective cell migration
04

Disease associations

CancerViral infectionInflammationMetastasisAutoimmune disease
05

Safety considerations

Immune-related adverse events (irAEs) due to checkpoint inhibition [2]Increased risk of opportunistic infections such as progressive multifocal leukoencephalopathy (PML) with integrin-blocking therapy [1]Impaired wound healing and tissue repair [7]Systemic toxicity from broad expression of adhesion molecules in normal tissues [1]
06

Interacting drugs

Natalizumab

5 more in the full profile.

07

Biomarkers

PD-L1 expressionE-cadherin levelICAM-1 expressionIntegrin alpha-4 expression

Beyond the preview

Go deeper on Cell-to-cell contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-to-cell contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call